Multiplex Assay Kit for Syndecan 4 (SDC4) ,etc. by FLIA (Flow Luminescence Immunoassay)

SYND4; Amphiglycan; Ryudocan; Ryudocan core protein

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Syndecan 4 (SDC4) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Syndecan 4 (SDC4) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Syndecan 4 (SDC4) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Syndecan 4 (SDC4) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 86-96 89
EDTA plasma(n=5) 79-88 84
heparin plasma(n=5) 84-91 87
sodium citrate plasma(n=5) 93-103 98

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Syndecan 4 (SDC4) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Syndecan 4 (SDC4) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Syndecan 4 (SDC4) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 85-98% 84-101% 83-99% 78-92%
EDTA plasma(n=5) 85-92% 85-99% 82-96% 85-96%
heparin plasma(n=5) 93-102% 78-89% 99-105% 90-97%
sodium citrate plasma(n=5) 83-97% 96-103% 95-105% 80-96%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:SDC4) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Lipids in Health and Disease The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy–5-year follow-up PubMed: PMC3641983
The FASEB Journal Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor α: a contributor to endothelial cell glycocalyx dysfunction Pubmed:25122554
Scientific Reports Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension PubMed: 25747153
Int J Mol Sci The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension PubMed: 25984599
Biochemical and Biophysical Research Communications Syndecan-4 shedding impairs macrovascular angiogenesis in diabetes mellitus Pubmed:27018253
Kidney International Aldosterone induces albuminuria via matrix metalloproteinase–dependent damage of the endothelial glycocalyx Pubmed: 30389198
Catalog No. Related products for research use of Rattus norvegicus (Rat) Organism species Applications (RESEARCH USE ONLY!)
RPB939Ra01 Recombinant Syndecan 4 (SDC4) Positive Control; Immunogen; SDS-PAGE; WB.
PAB939Ra01 Polyclonal Antibody to Syndecan 4 (SDC4) WB; IHC; ICC; IP.
LAB939Ra71 Biotin-Linked Polyclonal Antibody to Syndecan 4 (SDC4) WB; IHC; ICC.
LAB939Ra81 FITC-Linked Polyclonal Antibody to Syndecan 4 (SDC4) WB; IHC; ICC; IF.
MAB939Ra21 Monoclonal Antibody to Syndecan 4 (SDC4) WB; IHC; ICC; IP.
SEB939Ra ELISA Kit for Syndecan 4 (SDC4) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB939Ra Multiplex Assay Kit for Syndecan 4 (SDC4) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.